NCT06429150 2024-06-10Frontline Combination CAR-T Cell Therapy for Multiple Myeloma or PlasmacytomaShenzhen Geno-Immune Medical InstitutePhase 1/2 Recruiting20 enrolled
NCT05521802 2023-03-24A Study of C-CAR088 in Patients With Relapsed or Refractory Multiple MyelomaShanghai AbelZeta Ltd.Phase 1/2 Recruiting92 enrolled